Mutations specified the fact that, as stated below, CLL therapy is based over the existence or absence of these mutations. The existing consensus is, in addition to clonal mutations, subclonal mutations with a variant allelic frequency ranging from 5 to ten% (and therefore under the threshold of detection by common https://alfreds641ksz3.activablog.com/profile